Page last updated: 2024-09-05

enzastaurin and Non-alcoholic Fatty Liver Disease

enzastaurin has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akazawa, Y; Billadeau, DD; Bronk, SF; Cazanave, SC; Elmi, NA; Gores, GJ; Ibrahim, SH; Werneburg, NW1

Other Studies

1 other study(ies) available for enzastaurin and Non-alcoholic Fatty Liver Disease

ArticleYear
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
    Journal of hepatology, 2011, Volume: 54, Issue:4

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Cell Line; Cells, Cultured; DNA Primers; Enzyme Activation; Enzyme Inhibitors; Fatty Liver; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Mice; Non-alcoholic Fatty Liver Disease; Palmitates; Proto-Oncogene Proteins; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Proteins

2011